vs
怪兽饮料（MNST）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
怪兽饮料的季度营收约是瑞思迈的1.5倍（$2.1B vs $1.4B），瑞思迈净利率更高（27.6% vs 21.1%，领先6.5%），怪兽饮料同比增速更快（17.6% vs 11.0%），怪兽饮料自由现金流更多（$351.2M vs $311.2M），过去两年瑞思迈的营收复合增速更高（9.0% vs 5.9%）
怪兽饮料是美国知名饮品企业，旗下拥有魔爪、Relentless、Reign、Burn等多款畅销能量饮料产品。公司1935年创立于美国南加州，前身为Hansen's，最初主营果汁产品，2012年正式更为现名。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
MNST vs RMD — 直观对比
营收规模更大
MNST
是对方的1.5倍
$1.4B
营收增速更快
MNST
高出6.6%
11.0%
净利率更高
RMD
高出6.5%
21.1%
自由现金流更多
MNST
多$40.0M
$311.2M
两年增速更快
RMD
近两年复合增速
5.9%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.1B | $1.4B |
| 净利润 | $449.2M | $392.6M |
| 毛利率 | 55.5% | 61.8% |
| 营业利润率 | 25.5% | 34.6% |
| 净利率 | 21.1% | 27.6% |
| 营收同比 | 17.6% | 11.0% |
| 净利润同比 | 65.9% | 13.9% |
| 每股收益（稀释后） | — | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MNSTRMD
| Q4 25 | $2.1B | $1.4B | ||
| Q3 25 | $2.2B | $1.3B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $1.8B | $1.3B | ||
| Q3 24 | $1.9B | $1.2B | ||
| Q2 24 | $1.9B | $1.2B | ||
| Q1 24 | $1.9B | $1.2B |
净利润MNSTRMD
| Q4 25 | $449.2M | $392.6M | ||
| Q3 25 | $524.5M | $348.5M | ||
| Q2 25 | $488.8M | $379.7M | ||
| Q1 25 | $443.0M | $365.0M | ||
| Q4 24 | $270.7M | $344.6M | ||
| Q3 24 | $370.9M | $311.4M | ||
| Q2 24 | $425.4M | $292.2M | ||
| Q1 24 | $442.0M | $300.5M |
毛利率MNSTRMD
| Q4 25 | 55.5% | 61.8% | ||
| Q3 25 | 55.7% | 61.5% | ||
| Q2 25 | 55.7% | 60.8% | ||
| Q1 25 | 56.5% | 59.3% | ||
| Q4 24 | 55.3% | 58.6% | ||
| Q3 24 | 53.2% | 58.6% | ||
| Q2 24 | 53.6% | 58.5% | ||
| Q1 24 | 54.1% | 57.9% |
营业利润率MNSTRMD
| Q4 25 | 25.5% | 34.6% | ||
| Q3 25 | 30.7% | 33.4% | ||
| Q2 25 | 29.9% | 33.7% | ||
| Q1 25 | 30.7% | 33.0% | ||
| Q4 24 | 21.0% | 32.5% | ||
| Q3 24 | 25.5% | 31.6% | ||
| Q2 24 | 27.7% | 31.2% | ||
| Q1 24 | 28.5% | 31.3% |
净利率MNSTRMD
| Q4 25 | 21.1% | 27.6% | ||
| Q3 25 | 23.9% | 26.1% | ||
| Q2 25 | 23.1% | 28.2% | ||
| Q1 25 | 23.9% | 28.3% | ||
| Q4 24 | 14.9% | 26.9% | ||
| Q3 24 | 19.7% | 25.4% | ||
| Q2 24 | 22.4% | 23.9% | ||
| Q1 24 | 23.3% | 25.1% |
每股收益（稀释后）MNSTRMD
| Q4 25 | — | $2.68 | ||
| Q3 25 | — | $2.37 | ||
| Q2 25 | — | $2.58 | ||
| Q1 25 | — | $2.48 | ||
| Q4 24 | — | $2.34 | ||
| Q3 24 | — | $2.11 | ||
| Q2 24 | — | $1.97 | ||
| Q1 24 | — | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.8B | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $8.3B | $6.3B |
| 总资产 | $10.0B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资MNSTRMD
| Q4 25 | $2.8B | $1.4B | ||
| Q3 25 | $2.6B | $1.4B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $1.9B | $932.7M | ||
| Q4 24 | $1.5B | $521.9M | ||
| Q3 24 | $1.6B | $426.4M | ||
| Q2 24 | $1.6B | $238.4M | ||
| Q1 24 | $3.6B | $237.9M |
总债务MNSTRMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | $199.1M | $663.1M | ||
| Q4 24 | $374.0M | $662.9M | ||
| Q3 24 | $748.8M | $667.6M | ||
| Q2 24 | $748.7M | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益MNSTRMD
| Q4 25 | $8.3B | $6.3B | ||
| Q3 25 | $7.7B | $6.1B | ||
| Q2 25 | $7.2B | $6.0B | ||
| Q1 25 | $6.5B | $5.5B | ||
| Q4 24 | $6.0B | $5.3B | ||
| Q3 24 | $5.8B | $5.2B | ||
| Q2 24 | $5.9B | $4.9B | ||
| Q1 24 | $8.6B | $4.6B |
总资产MNSTRMD
| Q4 25 | $10.0B | $8.5B | ||
| Q3 25 | $9.6B | $8.3B | ||
| Q2 25 | $8.7B | $8.2B | ||
| Q1 25 | $8.2B | $7.6B | ||
| Q4 24 | $7.7B | $7.1B | ||
| Q3 24 | $8.1B | $7.2B | ||
| Q2 24 | $8.1B | $6.9B | ||
| Q1 24 | $10.1B | $6.8B |
负债/权益比MNSTRMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | 0.03× | 0.12× | ||
| Q4 24 | 0.06× | 0.13× | ||
| Q3 24 | 0.13× | 0.13× | ||
| Q2 24 | 0.13× | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $379.4M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $351.2M | $311.2M |
| 自由现金流率自由现金流/营收 | 16.5% | 21.9% |
| 资本支出强度资本支出/营收 | 1.3% | 2.0% |
| 现金转化率经营现金流/净利润 | 0.84× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $2.0B | $1.8B |
8季度趋势，按日历期对齐
经营现金流MNSTRMD
| Q4 25 | $379.4M | $339.7M | ||
| Q3 25 | $745.1M | $457.3M | ||
| Q2 25 | $466.0M | $538.8M | ||
| Q1 25 | $507.6M | $578.7M | ||
| Q4 24 | $461.7M | $308.6M | ||
| Q3 24 | $618.4M | $325.5M | ||
| Q2 24 | $436.3M | $440.1M | ||
| Q1 24 | $412.1M | $402.0M |
自由现金流MNSTRMD
| Q4 25 | $351.2M | $311.2M | ||
| Q3 25 | $701.5M | $414.4M | ||
| Q2 25 | $434.6M | $508.2M | ||
| Q1 25 | $478.5M | $557.9M | ||
| Q4 24 | $370.4M | $288.0M | ||
| Q3 24 | $571.4M | $307.7M | ||
| Q2 24 | $376.5M | $415.2M | ||
| Q1 24 | $346.1M | $380.8M |
自由现金流率MNSTRMD
| Q4 25 | 16.5% | 21.9% | ||
| Q3 25 | 31.9% | 31.0% | ||
| Q2 25 | 20.6% | 37.7% | ||
| Q1 25 | 25.8% | 43.2% | ||
| Q4 24 | 20.4% | 22.5% | ||
| Q3 24 | 30.4% | 25.1% | ||
| Q2 24 | 19.8% | 33.9% | ||
| Q1 24 | 18.2% | 31.8% |
资本支出强度MNSTRMD
| Q4 25 | 1.3% | 2.0% | ||
| Q3 25 | 2.0% | 3.2% | ||
| Q2 25 | 1.5% | 2.3% | ||
| Q1 25 | 1.6% | 1.6% | ||
| Q4 24 | 5.0% | 1.6% | ||
| Q3 24 | 2.5% | 1.5% | ||
| Q2 24 | 3.1% | 2.0% | ||
| Q1 24 | 3.5% | 1.8% |
现金转化率MNSTRMD
| Q4 25 | 0.84× | 0.87× | ||
| Q3 25 | 1.42× | 1.31× | ||
| Q2 25 | 0.95× | 1.42× | ||
| Q1 25 | 1.15× | 1.59× | ||
| Q4 24 | 1.71× | 0.90× | ||
| Q3 24 | 1.67× | 1.05× | ||
| Q2 24 | 1.03× | 1.51× | ||
| Q1 24 | 0.93× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MNST
| Monster Energy Drinks Segment | $1.2B | 57% |
| Sales Revenue Product Line | $905.5M | 42% |
| Strategic Brands Segment | $50.3M | 2% |
| Alcohol Brands Segment | $29.0M | 1% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
